Comparative effectiveness and safety of different types of inhaled long-acting β2-agonist plus inhaled long-acting muscarinic antagonist vs inhaled long-acting β2 …
Background Despite multiple available fixed-dose combinations (FDCs) of inhaled long-
acting β 2-agonists (LABAs) plus long-acting muscarinic antagonists (LAMAs) and LABAs …
acting β 2-agonists (LABAs) plus long-acting muscarinic antagonists (LAMAs) and LABAs …
Interclass difference in pneumonia risk in COPD patients initiating fixed dose inhaled treatment containing extrafine particle beclometasone versus fine particle …
Background Inhaled corticosteroids (ICS) afford therapeutic benefits in some COPD patients,
but their widespread use is cautioned due to an increased risk of developing pneumonia …
but their widespread use is cautioned due to an increased risk of developing pneumonia …
Revisión narrativa de la terapia inhalatoria en la EPOC
AL Aguilar-Shea, C Gallardo-Mayo - Medicina de Familia. SEMERGEN, 2022 - Elsevier
La terapia inhalada con broncodilatadores de acción larga es la base del tratamiento
farmacológico de la EPOC. Con el fin conocer los que ofrecen un mejor control, se realizó …
farmacológico de la EPOC. Con el fin conocer los que ofrecen un mejor control, se realizó …
Revisión narrativa de la terapia inhalatoria en la EPOC
MV Martínez, EC Manuel, AL Aguilar-Shea - Medicina de Familia …, 2024 - Elsevier
La base del tratamiento de mantenimiento de la EPOC son los broncodilatadores de acción
larga y los corticoides inhalados. Frente a las modificaciones recientes en las guías de …
larga y los corticoides inhalados. Frente a las modificaciones recientes en las guías de …
[HTML][HTML] Clinical efficacy of glucocorticoid and terbutaline in the treatment of acute exacerbation of chronic obstructive pulmonary disease
Y Li, Z Xu, C Qing, H Zhang, X Wu… - American Journal of …, 2021 - ncbi.nlm.nih.gov
Background: To investigate the efficacy of glucocorticoid and terbutaline in the treatment of
acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Methods: 248 …
acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Methods: 248 …
[HTML][HTML] Optimization of Long-Acting Bronchodilator Dose Ratios Using Isolated Guinea Pig Tracheal Rings for Synergistic Combination Therapy in Asthma and COPD
The co-administration of a long-acting β2-agonist (LABA), and a long-acting muscarinic
antagonist (LAMA), has been shown to be beneficial in the management of non …
antagonist (LAMA), has been shown to be beneficial in the management of non …
[HTML][HTML] К лечению бронхиальной астмы и хронической обструктивной болезни легких: идем вперед с проверенными молекулами
АА Визель, АС Белевский, ИЮ Визель - Лечебное дело, 2020 - cyberleninka.ru
Хроническая обструктивная болезнь легких и бронхиальная астма являются наиболее
распространенными хроническими инвалидизирующими обструктивными …
распространенными хроническими инвалидизирующими обструктивными …
Polypharmacology in Clinical Applications: Respiratory Polypharmacology
Z Wang, B Yang - Polypharmacology: Principles and Methodologies, 2022 - Springer
The respiratory system is an open system that allows us to breathe, bring oxygen into our
bodies (called inspiration or inhalation), and send carbon dioxide out (called expiration, or …
bodies (called inspiration or inhalation), and send carbon dioxide out (called expiration, or …
Incidence of Oral Candidiasis in Patients with Asthma Using Inhaled Corticosteroids by Various Inhaler Devices
Objective: The aim of this study was to do the comparison of the incidence of oral
candidiasis in individuals with inhaled corticosteroids by Rota caps via Revolizer and …
candidiasis in individuals with inhaled corticosteroids by Rota caps via Revolizer and …
[图书][B] Long-acting β2 adrenergic agonists (LABAs) provoke Th17-biased asthma
CM Kook - 2020 - search.proquest.com
Asthma is a heterogeneous disease with distinct features of airway hyper-responsiveness
(AHR) and mucus secretion. In general, long-acting β2 adrenergic agonists (LABAs) are …
(AHR) and mucus secretion. In general, long-acting β2 adrenergic agonists (LABAs) are …